# A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

> **NCT05977998** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Gastric Adenocarcinoma
- Carcinomatosis

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Dexamethasone
- **DRUG:** Diphenhydramine
- **DRUG:** Famotidine

## Key facts

- **NCT ID:** NCT05977998
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-08
- **Primary completion:** 2028-10-31
- **Final completion:** 2030-10-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05977998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05977998, "A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05977998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*